【摘要】 目的探讨经尿道双极等离子汽化电切术(PKRP)治疗高危复发性前列腺增生症的临床效果与安全性。方法对2008年8月至2013年5月间在我院接受经尿道双极等离子汽化电切术治疗的高危复发性前列腺增生症26例患者进行回顾性研究,分析术前及术后6个月、12个月国际前列腺症状评分(IPSS)、生活质量评分(QOL)、最大尿流率(Qmax)、膀胱残余尿(PVR)以及前列腺特异性抗原(PSA)等指标,评估其疗效。结果 26例患者平均手术时间(52.4±23.5)min,术后均未输血及使用止血、血管活性药物。术后3月、6个月IPSS、QOL、Qmax、PVR、PSA各指标较术前明显改善(P<0.05)。术后12个月较术后6个月无明显的改变(P>0.05)。结论经尿道双极等离子汽化电切术治疗高危复发性前列腺增生具有安全性高、临床效果显著的特点,具有良好的应用前景。更多还原

【Abstract】 Objective To explore the efficacy and safty on plasma kinetic resection of the prostate(PKRP) for the treatment of high risk recurrent benign prostatic hyperplasia(BPH). Methods Clinical data of 26 patients with high risk recurrent BPH were analyzed retrospectively. The clinical factors including IPSS, QOL, Qmax, PVR and PSA between the preoperation and 6-month, 12-month postoperation were compared. Results The mean operative time was(52.4±23.5)min. No case needed blood transfusion and vasoactive drugs postoperativly. Significant differences between the preoperation and 3-month, 6-month postoperation were found in IPSS, QOL, Qmax, PVR and PSA(P <0.05), indicating improvement after PKRP. No significant difference was found between 6-month and 12-month postoperation. Conclusion PKRP is a feasible, effective and safe method for treatment of high risk recurrent BPH and may have a promising future.更多还原